Increased MS relapse rate during assisted reproduction technique.
Hellwig
Kerstin
K
Beste
Christian
C
Brune
Niels
N
Haghikia
Aiden
A
Müller
Thomas
T
Schimrigk
Sebastian
S
Gold
Ralf
R
D000328:Adult; D004967:Estrogens / Q000009:adverse effects / Q000378:metabolism; D005260:Female; D005307:Fertilization in Vitro; D012739:Gonadal Steroid Hormones / Q000009:adverse effects* / Q000378:metabolism*; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists / Q000037:antagonists & inhibitors; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000139:chemically induced* / Q000378:metabolism* / Q000503:physiopathology; D011247:Pregnancy; D011374:Progesterone / Q000009:adverse effects / Q000378:metabolism; D027724:Reproductive Techniques, Assisted / Q000009:adverse effects*; D012189:Retrospective Studies; D055502:Secondary Prevention; D013312:Stress, Physiological / Q000150:complications / Q000276:immunology / Q000503:physiopathology; D013375:Substance Withdrawal Syndrome / Q000276:immunology / Q000503:physiopathology; D011795:Surveys and Questionnaires
D004967:Estrogens; D012739:Gonadal Steroid Hormones; D007155:Immunologic Factors; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone